[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:chronic-small-plaque-psoriasis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":159,"states":160},"Chronic small plaque psoriasis",24,21,[8,16,22,29,35,41,47,53,60,67,73,79,85,91,97,104,110,115,121,127,133,139,146,152],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07449702","An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis",[12],"Phase 2","RECRUITING","2026-08-26T02:16:12.203827Z","2026-07-05T05:32:16.681257Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07489885","A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis",[12],"2026-08-26T02:18:42.501841Z","2026-07-05T03:45:20.251317Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06807424","A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis",[26],"Phase 3","2026-08-26T02:16:45.157238Z","2026-06-16T05:54:07.923432Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07250802","A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis",[26],"2026-08-26T02:16:08.402952Z","2026-05-05T02:43:29.696343Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07116967","Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)",[26],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:29.527146Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07474792","Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis",[12],"2026-08-26T02:15:17.167444Z","2026-05-05T02:43:29.495939Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06425549","A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis",[26],"2026-08-03T03:38:13.938630Z","2026-05-05T02:43:29.184393Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":58,"content_modified":59},"NCT07024602","A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis",[57],"Phase 1","2026-08-26T02:18:14.396999Z","2026-05-05T02:43:29.131208Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":65,"content_modified":66},"NCT05270733","Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics",[64],"Phase 4","2026-08-26T02:16:06.684983Z","2026-05-05T02:43:28.672520Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT04347473","ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.",[64],"2026-08-26T02:15:59.318403Z","2026-05-05T02:43:28.472448Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT07290569","Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis",[12],"2026-08-03T02:13:39.904259Z","2026-05-05T02:43:28.124817Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT05642182","Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques",[57],"2026-08-26T02:19:02.550788Z","2026-05-05T02:43:28.122158Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06979453","A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis",[26],"2026-08-26T02:16:55.892527Z","2026-05-05T02:43:28.011173Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT03827876","Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis",[64],"2026-08-26T02:15:20.225313Z","2026-05-05T02:43:27.637904Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":102,"content_modified":103},"NCT04036188","Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis",[101],"Early Phase 1","2026-08-26T02:17:35.666428Z","2026-05-05T02:43:27.335641Z",{"nct_id":105,"title":106,"phases":107,"status":13,"updated_at":108,"content_modified":109},"NCT03987763","A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis",[64],"2026-08-26T02:15:49.658025Z","2026-05-05T02:35:31.932499Z",{"nct_id":111,"title":112,"phases":113,"status":13,"updated_at":83,"content_modified":114},"NCT07362017","Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis",[26],"2026-06-14T18:39:22.240337Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT07615712","PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study",[],"2026-08-26T02:15:36.077529Z","2026-05-29T15:36:40.233898Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT05744466","A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis",[],"2026-08-26T02:15:28.524219Z","2026-05-13T02:55:06.374371Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT04846959","Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications",[],"2026-08-26T02:16:44.178623Z","2026-05-13T02:55:06.271941Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT06888193","A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)",[57],"2026-08-26T02:17:07.954622Z","2026-05-05T02:43:29.527790Z",{"nct_id":140,"title":141,"phases":142,"status":143,"updated_at":144,"content_modified":145},"NCT07725822","An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis",[64],"NOT_YET_RECRUITING","2026-08-26T02:15:33.331531Z","2026-07-30T01:46:14.448025Z",{"nct_id":147,"title":148,"phases":149,"status":143,"updated_at":150,"content_modified":151},"NCT06338358","Understanding Participation Habits Among Plaque Psoriasis Patients",[],"2026-08-26T02:17:56.243868Z","2026-05-13T02:55:06.436138Z",{"nct_id":153,"title":154,"phases":155,"status":156,"updated_at":157,"content_modified":158},"NCT06506916","A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis",[26],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:32.170340Z","2026-05-05T02:43:27.949868Z",[],[161,165,169,173,177,180,183,187,190,193,197,200,204,207,210,213,216,220,223,226,229,233,236,239],{"state":162,"count":163,"slug":164},"Florida",14,"florida",{"state":166,"count":167,"slug":168},"California",13,"california",{"state":170,"count":171,"slug":172},"Texas",10,"texas",{"state":174,"count":175,"slug":176},"Massachusetts",8,"massachusetts",{"state":178,"count":175,"slug":179},"New York","new-york",{"state":181,"count":175,"slug":182},"Ohio","ohio",{"state":184,"count":185,"slug":186},"Arizona",7,"arizona",{"state":188,"count":185,"slug":189},"North Carolina","north-carolina",{"state":191,"count":185,"slug":192},"Pennsylvania","pennsylvania",{"state":194,"count":195,"slug":196},"Illinois",6,"illinois",{"state":198,"count":195,"slug":199},"Washington","washington",{"state":201,"count":202,"slug":203},"Alabama",5,"alabama",{"state":205,"count":202,"slug":206},"Indiana","indiana",{"state":208,"count":202,"slug":209},"Maryland","maryland",{"state":211,"count":202,"slug":212},"Michigan","michigan",{"state":214,"count":202,"slug":215},"South Carolina","south-carolina",{"state":217,"count":218,"slug":219},"Kentucky",4,"kentucky",{"state":221,"count":218,"slug":222},"New Jersey","new-jersey",{"state":224,"count":218,"slug":225},"Oregon","oregon",{"state":227,"count":218,"slug":228},"Virginia","virginia",{"state":230,"count":231,"slug":232},"Arkansas",3,"arkansas",{"state":234,"count":231,"slug":235},"Georgia","georgia",{"state":237,"count":231,"slug":238},"Minnesota","minnesota",{"state":240,"count":231,"slug":241},"Wisconsin","wisconsin"]